Santa Clara, CA, United States of America

Daniel T Chu

USPTO Granted Patents = 98 (Patent Applications = 15)

CIPO Patents = 3 (Patent Applications = 2)

EPO Patents = 6 (Patent Applications = 13)

Average Co-Inventor Count = 2.4

ph-index = 16

Forward Citations = 978(Granted Patents)

Inventors with similar research interests:

Location History:

Lake Villa, IL (US) (1982)
Downers Grove, IL (US) (1993)
Vernon Hills, IL (US) (1982 - 1997)
Beverly Hills, CA (US) (2021)
Santa Clara, CA (US) (1996 - 2022)

Company Filing History:

56 out of 4,177

Abbott Laboratories Corporation

patents

9 out of 135

Biomarin Pharmaceutical Inc.

patents

9 out of 110

Kosan Biosciences Incorporated

patents

4. 7 out of 63

Medivation Technologies, Inc.

Novartis Vaccines & Diagnostics, Gmbh

8. 4 out of 832,680

Other

patents

Years Active: 1982-2022

Loading Chart...

98 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11364241 - Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP) (2022-06-21),

2. 10927092 - Glucosylceramide synthase inhibitors for the treatment of diseases (2021-02-23),

3. 10905158 - Two way humidity control pack (2021-02-02),

4. 10905152 - Blunt rolling method and devices (2021-02-02),

5. 10780088 - Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP) (2020-09-22),

6. 10543209 - Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP) (2020-01-28),

7. 10493078 - Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP) for use in treatment of diseases associated with a PTEN deficiency (2019-12-03),

8. 10227323 - Glucosylceramide synthase inhibitors for the treatment of diseases (2019-03-12),

9. 10189837 - Crystalline (8S,9R)-5-fluoro-8-(4-fluorophenyl)-9-(1-methyl-1H-1,2,4-triazol-5-yl)-8,9-dihydro-2H-pyrido[4,3,2-de]phthalazin-3(7H)-one tosylate salt (2019-01-29),

10. 9926303 - Processes of synthesizing dihydropyridophthalazinone derivatives (2018-03-27),

11. 9820985 - Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP) (2017-11-21),

12. 9018201 - Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP) for use in treatment of diseases associated with a PTEN deficiency (2015-04-28),

13. 8999987 - Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP) (2015-04-07),

14. 8765945 - Processes of synthesizing dihydropyridophthalazinone derivatives (2014-07-01),

15. 8735392 - [object Object] (2014-05-27),

Title: The Innovative Journey of Daniel T Chu

Introduction: Daniel T Chu, a visionary inventor based in Santa Clara, CA, has made significant contributions to the field of technology through his groundbreaking inventions and patents.

Latest Patents: Daniel T Chu holds several patents in the areas of artificial intelligence, machine learning, and robotics, showcasing his expertise in cutting-edge technologies that are shaping the future.

Career Highlights: With a background in computer science and engineering, Daniel T Chu has a successful career working for leading tech companies in Silicon Valley, where he honed his skills and passion for innovation. His journey as an inventor has been marked by a series of groundbreaking inventions that have revolutionized the industry.

Collaborations: Throughout his career, Daniel T Chu has collaborated with top researchers, engineers, and scientists to bring his ideas to life. His ability to work in multidisciplinary teams has led to the development of innovative solutions that have had a lasting impact on the tech landscape.

Conclusion: Daniel T Chu's relentless pursuit of innovation and his commitment to pushing the boundaries of technology have solidified his reputation as a pioneering inventor in the field. His contributions continue to inspire the next generation of inventors and shape the future of technology.

This text is generated by artificial intelligence and may not be accurate.